NEW UK Autism Research Hub: The Synapse Centre for Neurodevelopment ESNEFT
NEW UK Autism Research Hub: The Synapse Centre for Neurodevelopment ESNEFT The Synapse Centre for Neurodevelopment The Synapse Centre, based within the ESNEFT (East Suffolk and North Essex NHS Foundation Trust) is a new research centre based in the East of England...
Synchrony 2020 Online Symposium – Translational Research In Autism
Synchrony 2020 Online Symposium – Translational Research In Autism Latest advancements in autism research and development of approved therapeutics for improving health and quality of life of people with autism. We are happy to share the announcement that the second...
Addressing Poor Health & High Death Rates in Autism
Addressing Poor Health & High Death Rates in Autism “We must first recognise ASD as a whole body disorder” Autism, or Autism Spectrum Disorder ASD, is traditionally seen as the result of behavioural and neuropsychiatric dysfunction. However there is a strong...
Brain Plasticity in Autism- new approaches from Yale University
All brains are able to change by forming new neural connections. This ability to change is known neuroplasticity or brain plasticity. The capacity of the brain to, under the right circumstances, re-organize itself physically and functionally underpins trans-cranial Direct Current stimulation (tDCS) as a treatment modality. Harry D. Schneider PhD, MD, MPH, Consultant in Neurolinguistics to the Joy Hirsch PhD, Director of Brain Function Laboratory, Yale University School of Medicine, will share his decades of research and clinical experience of tDCS…
Synchrony 2019 – Translational Research in Autism symposia
The first Brain Foundation annual symposia, Pleasanton, California 8-10 of Nov 2019, aimed to connect researchers with clinicians, donors & stake holders to help translate research efforts into evidence-based treatments for autism and its co-morbidities. It highlighted the need for multidisciplinary collaboration, detailed diagnostics and personalised treatment…
Cannabis for Treating Core and Comorbid Autism Symptoms – Where are we at?
Several studies published in recent months investigated the effects of cannabis-based products for treating autism. Although the studies were open-label and relatively small in scale, the overall results were overwhelmingly positive, with statistically significant improvements in social communication, language, restrictive/repetitive and challenging behaviours.
An Introduction to Vision Therapy as a Treatment for Autism
I hope that my journey in vision therapy will serve not only as a roadmap for people with mild autism to find their way out of the labyrinth of disability but as something that can provide clues to help those with more severe autism find their way to a life more fully lived.
Turning the Tide of Behaviourism
Turning the Tide of Behaviourism Please find below some thoughts from Romulus Campan, an adult with autism and a delegate at our recent conference. I had the pleasure of talking to Rom at the conference. I cannot remember the last time I met someone so open-minded,...
Higher rates of autism in children with various congenital disorders
Children with Congenital Heart Disease, Tuberous Sclerosis Complex, Duchenne Muscular Dystrophy, Ehlers-Danlos Syndrome, Neurofibromatosis Type 1 suffer high rates of autism. Everolimus, an mTOR inhibitor with strong neuro-inflammation attenuating effects, reduces core autism symptoms in some children with TSC, epilepsy and autism…
Autism should be approached as a chronic health condition, scientists recommend
Numerous medical conditions are significantly more prevalent in children and adults with autism, including allergy and/or immunologic, musculoskeletal, neurologic, psychiatric and gastrointestinal conditions. Early childhood health problems can be used to spot children at high risk of autism…
